Haemonetics Announces Regulatory Clearances of NexSys PCS(TM) Enhanced Software with YES(TM) Technology

Embedded Software Adds Key Capability to NexSys PCS Platform BRAINTREE, Mass., March 28, 2018 -- (Healthcare Sales & Marketing Network) -- Haemonetics Corporation (NYSE: HAE) has received 510(k) clearance from the U.S. Food and Drug Administration (FDA... Devices, FDA, Regulatory Haemonetics, NexSys PCS, plasma

http://salesandmarketingnetwork.com/news_release_bs.html?ID=2043679

Source: HSMN NewsFeed - March 28, 2018 Category: Pharmaceuticals Source Type: news

More News: Food and Drug Administration (FDA) | Marketing | Pharmaceuticals